Does INLYTA Cause Off label use? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Off label use have been filed in association with INLYTA. This represents 2.4% of all adverse event reports for INLYTA.
12
Reports of Off label use with INLYTA
2.4%
of all INLYTA reports
5
Deaths
1
Hospitalizations
How Dangerous Is Off label use From INLYTA?
Of the 12 reports, 5 (41.7%) resulted in death, 1 (8.3%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for INLYTA. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does INLYTA Cause?
Disease progression (97)
Diarrhoea (96)
Death (75)
Fatigue (68)
Nausea (45)
Renal cancer (45)
Dysphonia (40)
Decreased appetite (33)
Asthenia (29)
Hypertension (26)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which INLYTA Alternatives Have Lower Off label use Risk?
INLYTA vs INOTERSEN
INLYTA vs INOTUZUMAB OZOGAMICIN
INLYTA vs INSULIN
INLYTA vs INSULIN ASPART
INLYTA vs INSULIN ASPART\INSULIN DEGLUDEC